MedTrace Logo

CANDIS-II: Evaluation of the Cognitive-behavioral Treatment Programme CANDIS

NCT00673647 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2009-08-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of the cognitive-behavioral treatment program CANDIS among n=450 patients with cannabis use disorders in a mulicenter randomized-controlled clinical trial (n=11 outpatient treatment centers).

Conditions

Interventions

BEHAVIORAL

Cognitive-behavioral treatment

10 sessions of individual psychotherapy including cognitive-behavioral treatment, motivational enhancement and a psychosocial problem training.

Sponsors & Collaborators

  • Federal Ministry of Health

    collaborator AMBIG

  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Hans-Ulrich Wittchen, PhD · Technische Universitaet Dresden

  • Gerhard Buehringer, PhD · Technische Universitaet Dresden

  • Eva Hoch, PhD · Technische Universitaet Dresden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2009-10-31
Completion
2009-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00673647 on ClinicalTrials.gov